News
Art of Startup: Bioscout
Australian Agtech startup, BioScout, is leading the world in monitoring and preventing crop disease. As well as potentially reducing crop waste, and costs and usage of chemicals, in the developed...
Art of Startup: Bioscout
Australian Agtech startup, BioScout, is leading the world in monitoring and preventing crop disease. As well as potentially reducing crop waste, and costs and usage of chemicals, in the developed...
MARKET UPDATE-21TH SEP 2022
Stoic property partner Elanor Investors Group is reportedly hoping to sell one of its premium assets, Peppers’ Cradle Mountain Lodge in Tasmania, and is confident it can secure a $100 million price...
MARKET UPDATE-21TH SEP 2022
Stoic property partner Elanor Investors Group is reportedly hoping to sell one of its premium assets, Peppers’ Cradle Mountain Lodge in Tasmania, and is confident it can secure a $100 million price...
Aussie chipmaker banks huge raise from Japanese...
Australia’s largest semiconductor maker, Morse Micro, has banked a $140 million funding round, backed by Japanese chip giant MegaChips, with a view to using its vast network to turbocharge the...
Aussie chipmaker banks huge raise from Japanese...
Australia’s largest semiconductor maker, Morse Micro, has banked a $140 million funding round, backed by Japanese chip giant MegaChips, with a view to using its vast network to turbocharge the...
MARKET UPDATE-14TH SEP 2022
The death of Queen Elizabeth II has dominated the news since Friday. Alongside this, the flow of political and financial news has been reduced by decisions to suspend both the...
MARKET UPDATE-14TH SEP 2022
The death of Queen Elizabeth II has dominated the news since Friday. Alongside this, the flow of political and financial news has been reduced by decisions to suspend both the...
Biotech startup OccuRx raises $16 million for k...
Biotech startup OccuRx has raised $16 million to fund clinical phase studies for its oral therapy to treat chronic kidney disease (CKD), a leading cause of death.
Biotech startup OccuRx raises $16 million for k...
Biotech startup OccuRx has raised $16 million to fund clinical phase studies for its oral therapy to treat chronic kidney disease (CKD), a leading cause of death.
MARKET UPDATE-7TH Sep 2022
The Reserve Bank of Australia raised the official interest rate by a further 50 basis points to 2.35 per cent on Tuesday.
MARKET UPDATE-7TH Sep 2022
The Reserve Bank of Australia raised the official interest rate by a further 50 basis points to 2.35 per cent on Tuesday.